Home > Insider Trading > Filing (0001562180-21-007531)

Filing Details

Accession Number:: 0001562180-21-007531
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-07 16:14:02
Reporting Period:: 2021-12-02

Accepted Time:: 2021-12-07 16:14:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1494174	H. Daniel Orenstein	C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-12-02	4,117	$41.95	71,429	No	4	F	Direct
Common Stock	Acquisiton	2021-12-03	2,500	$10.34	73,929	No	4	M	Direct
Common Stock	Disposition	2021-12-03	2,500	$42.87	71,429	No	4	S	Direct
Common Stock	Disposition	2021-12-06	1,100	$37.53	70,329	No	4	S	Direct
Common Stock	Disposition	2021-12-06	3,533	$38.60	66,796	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-12-03	2,500	$0.00	2,500	$10.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
118,500		2026-02-10	No	4	M	Direct

Footnotes

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $37.35 to $37.69 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $38.35 to $39.09 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) and (5).
25% of the 136,316 shares underlying the options vested in an annual installment on December 31, 2016 and the remaining balance vested in equal monthly installments until the option vested in full on Dec. 31, 2019.